Información del artículo
El Texto completo está disponible en PDF
Referencias
[1.]
T.D. Jones.
Diagnosis of rheumatic fever.
JAMA, 126 (1944), pp. 481-484
[2.]
D.D. Rutstein, W. Bauer, A. Dorfman, et al.
Jones criteria (modified) for guidance in the diagnosis of rheumatic fever.
Circulation, 13 (1956), pp. 617-620
[4.]
G.H. Stollerman, M. Markowitz, A. Taranta, et al.
Jones criteria (revised) for guidance in the diagnosis of rheumatic fever.
Circulation, 32 (1965), pp. 664-668
[5.]
F. Ramos-Niembro.
Enfermedades reumáticas. Criterios y diagnóstico.
McGraw-Hill Interamericana, (1999),
[6.]
D. Taylor.
A table for the degree of involvement in chronic arthritis.
Can Med Ass J, (1937), pp. 608-610
[7.]
K.D. Keele.
The pain chart.
Lancet, 255 (1948), pp. 6-8
[8.]
R. Likert.
A technique for the measurement of a hitudes.
Archives of Psychology, 140 (1932), pp. 44-60
[10.]
E.C. Huskisson.
Assessment for clinical trials.
Clin Rheum Dis, 2 (1976), pp. 37-50
[11.]
O. Steinbroker, C. Traeger, R. Batterman.
Therapeutic criteria for the rheumatoid arthritis.
JAMA, 140 (1949), pp. 659-662
[12.]
O. Steinbrocker, A. Blazer.
A therapeutic score card for rheumatoid arthritis.
N Engl J Med, 14 (1946), pp. 501-506
[13.]
O. Steinbroker, C. Traeger, R. Batterman.
Therapeutic criteria for the rheumatoid arthritis.
JAMA, 140 (1949), pp. 659-662
[14.]
P. Lee, M.K. Jasani, W.C. Dicj, et al.
Evaluation of a functional index in rheumatoid arthritis.
Scand J Rheumatol, 2 (1973), pp. 71-77
[15.]
E.W. Lowman.
Rehabilitation of the rheumatic cripple: a five year study.
Arthritis Rheum, 1 (1958), pp. 38-43
[16.]
F. Ramos-Niembro.
Enfermedades reumáticas. Criterios y diagnóstico.
McGraw-Hill Interamericana, (1999),
[17.]
M. Hochberg, R.W. Chang, I. Dwosh, S. Lindsey, T. Pincus, F. Wolfe.
The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis.
Arthritis Rheum, 35 (1992), pp. 498-502
[18.]
J. Lansbury.
Quantitation of the activity of rheumatoid arthritis. I. Method for recording its systemic manifestations.
Am J Med Sci, 231 (1956), pp. 616-621
[19.]
J. Lansbury.
Quantitation of the activity of rheumatoid arthritis. 2. Recession of morning stiffness as patients go into remission.
Am J Med Sci, 232 (1952), pp. 8-11
[20.]
J. Lansbury.
Quantitation of the activity of rheumatoid arthritis. 3. The maximum 5-minute Cutler sedimentation rate as an index.
Am J Med Sci, 232 (1956), pp. 12-16
[21.]
J. Lansbury, D.D. Haut.
Quantitation of the activity of rheumatoid arthritis. 4. Area of joint surfaces as an index to total joint inflammation and deformity.
Am J Med Sci, 232 (1956), pp. 150-155
[22.]
J. Lansbury.
Quantitation of the activity of rheumatoid arthritis. 5. A method for summation of the systemic indices or rheumatoid activity.
Am J Med Sciences, 232 (1956), pp. 300-310
[23.]
J. Lansbury.
Quantitation of the activity of rheumatoid arthritis. 6. Correlation of the systemc and joint findings.
Am J Med Sciences, 233 (1957), pp. 375-378
[24.]
J.F. Fries, P. Spitz, R.G. Kranies, H.R. Holman.
Measurement of patient outcome in arthritis.
Arthritis Rheum, 23 (1980), pp. 137-145
[25.]
B. Bruce, J. Fries.
The Stanford health assessment questionnaire (HAQ): a review of its history, issues, progress, and documentation.
J Rheumatol, 30 (2003), pp. 167-178
[26.]
R.F. Meenan, J.H. Masion, J.J. Anderson, et al.
AIMS2. The content and properties of a revised and expanded. Arthritis Impact Measurement Scales Health Status Questionnaire.
Arthritis Rheum, 35 (1992), pp. 1-10
[27.]
B. Bruce, J.F. Fries.
The Health Assessment Questionnaire (HAQ).
Clinical Exp Rheumatol, 23 (2005), pp. 14-18
[28.]
T. Pincus, J.A. Summey, S.A. Soaci Jr., K.A. Wallston, N.P. Hummon.
Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire.
Arthritis Rheum, 26 (1983), pp. 1346-1353
[29.]
F. Wolfe, K. Michaud, T. Pincus.
Development and validation of the health assessment questionnaire II: A revised version of the health assessment questionnaire.
Arthritis Rheum, 50 (2004), pp. 3296-3305
[30.]
T. Pincus, L.F. Callahan, W.G. Sale, A.L. Brooks, L.E. Payne, W.K. Vaughn.
Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years.
Arthritis Rheum, 27 (1984), pp. 864-872
[31.]
T. Pincus, Y. Yazici, M. Bergman.
Development of a multi-dimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical care.
Clin Exp Rheumatol, 23 (2005), pp. 19-28
[32.]
F. Wolfe, M.A. Cathey.
The Assessment and prediction of functional disability in rheumatoid arthritis.
J Rheumatol, 18 (1991), pp. 1298-1306
[33.]
F. Wolfe, D.J. Hawley.
The long term outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients.
J Rheumatol, 25 (1998), pp. 2108-2117
[34.]
F. Wolfe.
Why the HAQ-II can be an effective substitute for the HAQ.
Clin Exp Rheumatol, 23 (2005), pp. 29-30
[35.]
R.F. Meenan, P.M. Gertman, J.H. Mason.
Measuring health status in arthritis. The arthritis impact measurement scales.
Arthritis Rheum, 23 (1980), pp. 146-152
[36.]
M.H. Cardiel, M. Abello –Banfi, R. Ruiz-Mercado, et al.
How to measure health status in rheumatoid arthritis in non –English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ- DI).
Clin Exp Rheumatol, 11 (1993), pp. 117-121
[37.]
B.M. Abello, M.H. Cardiel, R. Ruiz-Mercado, et al.
Quality of life in rheumatoid arthritis: validation of a Spanish version of the Arthritis Impact Measurement Scales (Spanish- AIMS).
J Rheumatol, 21 (1994), pp. 150-155
[38.]
M.L.L. Prevoo, van’t Hof Ma, H.H. Kuper, M.A. van Leeuwen, L.B.A. van de Putte, P.L.C.M. van Riel.
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.
Arthritis Rheum, 38 (1995), pp. 44-48
[39.]
D.M.F.M. Van der Heijide, M.A. van’t Hof, P.L.C.M. van Riel, et al.
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.
Ann Rheum Dis, 49 (1990), pp. 916-920
[40.]
D.M.F.M. Van der Heijide, M.A. van’t Hof, P.L.C.M. van Riel, et al.
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.
Ann Rheum Dis, 51 (1992), pp. 177-181
[41.]
R.K. Mallya, B.E.W. Mace.
The Assessment of disease activity in rheumatoid arthritis using a multivariate analysis.
Rheumatol Rehabil, 20 (1981), pp. 14-17
[42.]
L.F. Callahan, R.H. Brooks, J.A. Summey, et al.
Quantitative pain assessment for routine care of rheumatoid arthritis patients, using a pain scale based on activities of daily living and visual analog pain scale.
Arthritis Rheum, 30 (1987), pp. 630-636
[43.]
M.L.L. Prevoo, M. van Gestel, van’t Hof Ma, M.H. van Rijswijk, L.B.A. van de Putte, P.L.C.M. van Riel.
Remission in a prospective study of patients with rheumatoid arthritis.
Br J Rheumatol, 35 (1996), pp. 1101-1105
[44.]
P.L.C.M. Van Riel, A.M. VAN Gestel, L.B.A. van de Putte.
Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers.
Br Rheumatol, 35 (1996), pp. 4-7
[45.]
A.M. Van Gestel, M.L. Prevoo, M.A. van ‘t Hof, M.H. van Rijswijk, L.B. van de Putte, P.L. van Riel.
Development and validation of the European League against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League against Rheumatism Criteria.
Arthritis Rheum, 39 (1996), pp. 34-40
[46.]
A.M. Van Gestel, C.J. Haagsma, P.L.C.M. van Riel.
Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.
Arthritis Rheum, 41 (1998), pp. 1845-1850
[47.]
A.M. Van Gestel, J.J. Anderson, P.L.C.M. van Riel, et al.
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials.
J Rheumatol, 26 (1999), pp. 705-711
[48.]
M.L.L. Prevoo, van’t Hof Ma, H.H. Kuper, M.A. van Leeuwen, L.B.A. van de Putte, P.L.C.M. van Riel.
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.
Arthritis Rheum, 38 (1995), pp. 44-48
[49.]
P.L.C.M. Van Riel.
Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis.
Br J Rheumatol, 31 (1992), pp. 793-796
[50.]
J. Fransen, M.C.W. Creemers, P.L.C.M. van Riel.
Remission in rheumatoid arthritis: agreement of the disease activity score (DAS-28) with the ARA preliminary remission criteria.
Rheumatology, 43 (2004), pp. 1252-1255
[51.]
D. Ritchie, J.A. Boyle, J.M. McInnes, et al.
Clinical studies with an articular index for the assessment of joint tenderness in patient with rheumatoid arthritis.
Q. J. Med, 3 (1968), pp. 393-406
[52.]
P.L.C.M. Van Riel, A.M. Van Gestel.
Area under the curve for the American College of Rheumatology improvement criteria: a valid addition to existing criteria in rheumatoid arthritis?.
Arthritis Rheum, 44 (2001), pp. 1719-1722
[53.]
R.S. Pinals, A.T. Masi, R.A. Larsen.
Preliminary criteria for clinical in rheumatoid arthritis.
Arthritis Rheum, 24 (1981), pp. 1308-1315
[54.]
D. Aletaha, M.M. Ward, K.P. Machold, V.P.K. Nell, T. Stamm, J.S. Smolen.
Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states.
Arthritis Rheum, 52 (2005), pp. 2625-2636
[55.]
D.T. Felson, J.J. Anderson, M. Boers, et al.
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.
Arthritis Rheum, 36 (1993), pp. 7294
[56.]
J.S. Smolen.
The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT).
Br J Rheumatol, 31 (1992), pp. 219-220
[57.]
M. Boers, P. Tuqwell, D.T. Fellson, et al.
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.
J Rheumatol, 41 (1994), pp. 86-89
[58.]
C. Bombardier, P. Tugwell.
A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches.
J Rheumatol, 9 (1982), pp. 753-757
[59.]
C.H. Goldsmith, H.A. Smythr, A. Helewa.
Interpretation and power of a pooled index.
J Rheumatol, 20 (1993), pp. 575-578
[60.]
J.S. Smolen, F.C. Breedveld, M.H. Schiff, et al.
A simplified disease activity index for rheumatoid arthritis for use in clinical practice.
Rheumatology (Oxford), 42 (2003), pp. 244-257
[61.]
D. Alehata, V.P. Nell, T. Stamm, et al.
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.
Arthritis Res There, 7 (2005), pp. R796-R806
[62.]
M.W. Stewart, D.G. Palmer, A. Knight.
Self report articular index measure of arthritic activity: investigations of reliability, validity and sensitivity.
J Rheumatol, 17 (1990), pp. 1011-1015
[63.]
P.W. Thompson, A.J. Silman, J.R. Kirwan, et al.
Articular indices of joint inflammation in rheumatoid arthritis. Correlation with acute phase response.
Arthritis Rheum, 30 (1987), pp. 618-623
[64.]
J.H. Mason, J.J. Anderson, R.F. Meenan.
The rapid Assessment of Disease Activity in Rheumatology (RADAR) questionnaire. Validity and sensitivity to change of a patient self report measure of joint count and clinical status.
Arthritis Rheum, 35 (1992), pp. 156-162
[65.]
G. Stucki, M. Liang, S. Stucki, et al.
A self administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research.
Arthritis Rheum, 38 (1995), pp. 795
[66.]
T. Pincus, Y. Yazici, M. Bergman, R. Maclean, T. Harrington.
A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health a. Best practice & research.
Clinical rheumatology [Internet], 21 (2007), pp. 789-804
[67.]
Y. Yazici, M. Bergman, T. Pincus.
Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
The Journal of rheumatology [Internet], 35 (2008), pp. 603-609
[68.]
T. Pincus, C. Chung, O.G. Segurado, I. Amara, G.G. Koch.
An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis.
The Journal of rheumatology [Internet], 33 (2006), pp. 2146-2152
[69.]
T. Pincus, Y. Yazici, M.J. Bergman.
Beyond RAPID3 - practical use of the MDHAQ to improve doctor-patient communication.
Bulletin of the NYU hospital for joint diseases [Internet], 68 (2010), pp. 223-231
[70.]
Y. Yazici, M. Bergman, T. Pincus.
Time to Score Quantitative Rheumatoid Arthritis Measures : 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) Scores.
Journal of Rheumatology, (2008), pp. 603-609
[71.]
A.J. Amaya, Torralvo-MG, O.J. Calixto, R.R. Calderón, M.J. Caro, A.M. Domínguez, R.D. Mantilla, J.M. Anaya, A.V. Rojas.
Autoclinimetría en Artritis Reumatoide: Revisión Sistemática de la Literatura y Metanálisis. Patients-reported outcomes in rheumatoid arthritis: Systematic literature review and meta-analysis.
Revista Col de Reumatología, (2013),
Copyright © 2013. Asociación Colombiana de Reumatología
